Skip to Content

Imatinib Actavis

Licence status
Withdrawn: 16/05/2022
Active substances
Imatinib mesylate
Dosage Form
Capsule, hard
Licence number
EU/1/13/825/019-023
Licence holder
Actavis Group hf

Licence information

ATC code
L01XE Protein kinase inhibitors, L01XE01 imatinib
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal products subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued